• Investing
  • Stock
Round Table Thoughts
  • Economy
  • Editor’s Pick
Home Economy Key study in FDA abortion pill case at the Supreme Court was retracted in ‘partisan assault’ authors say
Economy

Key study in FDA abortion pill case at the Supreme Court was retracted in ‘partisan assault’ authors say

by February 8, 2024
by February 8, 2024 0 comment
Share
0
FacebookTwitterPinterestWhatsapp

A key study in the case against the FDA’s abortion pill approval at the Supreme Court has been retracted from an academic journal, and its authors say the move is an ‘unprovoked and partisan assault’ on scientific research.  

On March 26, the Supreme Court will hear arguments in a case challenging access to the abortion pill and the U.S. Food and Drug Administration’s regulatory approval process. The FDA made several moves, intending to make it easier to access and use the mifepristone pill in the wake of the overturning of Roe v. Wade last year. 

Legal arguments against the FDA’s push have cited a study published in 2021 which found that the rate of abortion-related emergency room visits following a chemical abortion increased over 500% from 2002 through 2015, according to an analysis of Medicaid claims data. That study was published by Sage Publishing, an academic publishing company. 

However, on Monday, Sage announced it had retracted that 2021 study and two others, citing that the authors of the study failed to list their associations with pro-life organizations as a conflict of interest. 

The author of the emergency room study, Dr. Jim Studnicki, is the vice president of data analytics for the Charlotte Lozier Institute (CLI), who was trained at Johns Hopkins University. He has a 50-year career conducting scientific research and has 70 peer-reviewed studies indexed in PubMed.

CLI is a non-profit research arm of the Susan B. Anthony Pro Life America group – one of the most successful pro-life advocacy groups in the country. CLI says they are a network of over 70 associate scholars who are ‘credentialed experts in medicine, statistical analysis, sociology, science, bioethics, public health, law, and social services for women and families.’ 

Roughly two years after the study was published, an initially anonymous reader wrote to Sage with a concern that the graphs and figures in the study misrepresented data and that Dr. Studnicki did not appropriately disclose his affiliations with a pro-life group. CLI responded to the concern, saying that ‘no errors, miscalculations or deceptive practices are identified.’ 

CLI also said that ‘the affiliations of all authors are documented in the paper. In addition, a bio sketch for each author is included with the paper. Funding support for the research from CLI is also disclosed.’

CLI notes in its response that part of the Committee on Publication Ethics’ definition of conflict of interest describes ‘those which may not be fully apparent, and which may influence the judgment of author, reviewers, and editors’ and ‘which, when revealed later, would make a reasonable reader feel misled or deceived.’

‘All relevant information was fully disclosed,’ CLI said.

CLI continued in its response to Sage that ‘This paper is the single most read in the journal Health Services Research and Managerial Epidemiology. It has been repeatedly referenced in legal cases and legislative discourse in many states. It has enriched the scientific discourse on the relative safety of chemical induced abortion.’

‘Most importantly, it is excellent science, and the methods and findings are unchallenged. We respectfully ask that you not allow ideologically motivated and unsubstantiated ‘concerns’ to damage the reputation of this work and its authors,’ they said.

Four months later, with very little communication in the meantime, Sage notified CLI they were retracting the three studies.

In response to an inquiry from Fox News Digital, Sage Publishing referred to its retraction notification which cites ‘undeclared conflicts of interest’ and ‘lack of scientific rigor.’ 

However, lawyers representing CLI told the publishing firm that ‘the allegations raised in support of retraction are not only procedurally flawed but meritless, and Sage’s actions are unlawful.’

‘Your decision also reflects a regrettable pattern of using scientific publications as a sword against unpopular findings—regardless of their objectivity. This further undermines the public’s confidence in scientific bodies and does a disservice to your mission to ‘advance knowledge,’’ CLI’s lawyer David A. Shaneyfelt wrote in a letter to Sage in November. 

‘Our clients have spent their careers building credibility and engaging in objective scientific discovery. Your decision to retract their articles, your recurring breach of confidentiality, and your blatant breach of contract have already done palpable damage to their reputation,’ Shaneyfelt wrote. 

He also alleged that the timing of the retraction was ‘concerning,’ considering the studies’ connection to the Supreme Court case Alliance for Hippocratic Medicine v. FDA.

Dr. Studnicki said in a statement to Fox News Digital, ‘I think Dobbs really accelerated this, there’s a sense of desperation among those in the abortion industry. They’ve always had the literature to themselves. All of the major health associations are pro-abortion, most of the journals are pro-abortion, all the academic departments in the universities are pro-abortion.’ 

‘It’s profoundly sad to me what is going on in science today. I’m at a point in my life, at 80 years old, where they won’t damage me,’ he said. ‘But what if I was a mid-career faculty member or someone aiming for tenure or trying to raise a family? Right now, the science industry’s message appears to be – ‘if we can do this to Dr. Studnicki, who’s had a 50-year career without blemish, imagine what we can do to you.’’ 

Tessa Longbons, a senior research associate for CLI, said, ‘this incident points to a larger, newer phenomenon, which is that many of our scientific institutions and publications no longer stand in defense of open inquiry.’

‘Rather, we’re seeing a biased elite faction across the medical community with all the power attempting to suppress any research that cuts against their approved, pro-abortion narrative,’ she said. 

‘Scientific research and publication should be grounded in science, not driven by ideology,’ she added. 

The authors of the study told Fox News Digital they will be taking appropriate legal action. 

This post appeared first on FOX NEWS
You Might Also Like
  • First on Fox: Massive donation to Trump from Jewish org amid anti-Israel campus protests
  • How the Democratic Party’s war on populism led to its self-destruction
  • Israel urges Palestinians to evacuate Rafah ahead of expected ground operation in Hamas stronghold
  • Reporter’s Notebook: Israel-Hamas war continues on deadly day for Israel, but its ‘determination remains’
Share
0
FacebookTwitterPinterestWhatsapp

previous post
Haley mocks Trump in effort to entice debate with former president ahead of SC primary: ‘Can’t hide’
next post
Trump recommends North Carolina GOP Chair Whatley to replace McDaniel at RNC: Source

You may also like

Intercepted phone calls reveal Russian frontline troops complaining of heavy...

September 5, 2023

VP Harris faces backlash in crucial swing state after her...

July 23, 2024

Hunter Biden tax probe began as ‘offshoot’ IRS investigation into...

June 23, 2023

As N.Y. Times investigates leaks, liberal newsrooms have the upper...

April 18, 2024

Alan Dershowitz leaves Democratic Party, cites DNC: ‘I was disgusted’

September 7, 2024

Four in five Americans fear nation spiraling into chaos, new...

July 17, 2024

New Mexico governor says Republicans should ‘thank’ her as tensions...

September 15, 2023

Biden had similar legal aid arrangement he slammed Trump over

April 13, 2024

Wisconsin Democrats propose near-elimination of cash bail

March 17, 2023

The Twitter Files and FDR’s Blue Eagle

December 24, 2022

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • How to Find Compelling Charts in Every Sector

      July 10, 2025
    • White House accuses Powell of mismanaging Federal Reserve, citing headquarters renovation

      July 10, 2025
    • Italian chocolate giant Ferrero to buy Kellogg’s Froot Loops maker

      July 10, 2025
    • OpenAI to release web browser in challenge to Google Chrome

      July 10, 2025
    • Sports executive charged with bid-rigging in Texas arena project

      July 10, 2025

    Popular Posts

    • 1

      Biden appointee played key role in recruiting Chinese...

      June 25, 2024 3,631 views
    • 2

      Trump-era China sanctions ended by Biden may be...

      June 27, 2024 2,919 views
    • 3

      Walz’s honeymoon with China gets fresh scrutiny as...

      August 9, 2024 2,607 views
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful...

      July 10, 2024 2,577 views
    • 5

      Harris VP pick spent years promoting research facility...

      August 29, 2024 2,451 views

    Categories

    • Economy (7,009)
    • Editor's Pick (2,171)
    • Investing (538)
    • Stock (2,662)

    Popular Posts

    • 1

      Biden appointee played key role in recruiting Chinese businesses to Delaware: ‘Longtime friends’

      June 25, 2024
    • 2

      Trump-era China sanctions ended by Biden may be revived under new House GOP bill

      June 27, 2024
    • 3

      Walz’s honeymoon with China gets fresh scrutiny as Harris camp blasts ‘lying’ critics

      August 9, 2024
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful of Chinese spy threats

      July 10, 2024
    • 5

      Harris VP pick spent years promoting research facility that collaborated with ‘Chinese military company’

      August 29, 2024

    Latest News

    • How to Find Compelling Charts in Every Sector

      July 10, 2025
    • White House accuses Powell of mismanaging Federal Reserve, citing headquarters...

      July 10, 2025
    • Italian chocolate giant Ferrero to buy Kellogg’s Froot Loops maker

      July 10, 2025

    Categories

    • Economy (7,009)
    • Editor's Pick (2,171)
    • Investing (538)
    • Stock (2,662)

    Disclaimer: RoundTableThoughts.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 RoundTableThoughts.com. All Rights Reserved.

    Round Table Thoughts
    • Investing
    • Stock
    Round Table Thoughts
    • Economy
    • Editor’s Pick

    Read alsox

    Nevada Gov. Joe Lombardo vetoes measure...

    June 2, 2023

    Tuesday’s elections will be ‘fascinating test’...

    November 8, 2023

    Pentagon’s AI plan must include offense...

    July 18, 2023
    Sign In

    Keep me signed in until I sign out

    Forgot your password?

    Password Recovery

    A new password will be emailed to you.

    Have received a new password? Login here